Form 4: Nevro Corp Director Transfers Shares to Revocable Trust
SEC Form 4 Filing
Director Susan E. Siegel transferred 6,754 shares of Nevro Corp stock to the Reed-Siegal Revocable Trust on June 25, 2024.
Summary
- On June 25, 2024, Susan E. Siegel, a director of Nevro Corp, transferred 6,754 shares of common stock to the Reed-Siegal Revocable Trust.
- The transaction was a gift, with a price of $0 per share.
- Following the transaction, Siegel directly owns 24,579 shares, which includes 19,169 restricted stock units.
- Additionally, 7,382 shares are held indirectly through the Reed-Siegal Revocable Trust, where Bob Reed and Susan Siegel serve as trustees.
Sentiment
Score: 5
Explanation: This Form 4 filing represents a routine transaction (transfer to a trust) and has neutral sentiment.
Industry Context
This is a routine disclosure of insider transactions and doesn't necessarily indicate a change in the company's outlook or performance. It is common for executives and directors to manage their personal holdings for estate planning purposes.
Stakeholder Impact
- The transfer of shares to a revocable trust is unlikely to have a direct impact on Nevro Corp's stakeholders.
Key Dates
| Date | Description |
|---|---|
| 06/25/2024 | Date of the share transfer to the Reed-Siegal Revocable Trust |
| 06/27/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.